Below are the most recent publications written about "Hyperaldosteronism" by people in Profiles.
-
Wulczyn K, Perez-Reyes E, Nussbaum RL, Park M. Primary aldosteronism associated with a germline variant in CACNA1H. BMJ Case Rep. 2019 May 23; 12(5).
-
Vaidya A, Mulatero P, Baudrand R, Adler GK. The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment. Endocr Rev. 2018 12 01; 39(6):1057-1088.
-
Ruhle BC, White MG, Alsafran S, Kaplan EL, Angelos P, Grogan RH. Keeping primary aldosteronism in mind: Deficiencies in screening at-risk hypertensives. Surgery. 2019 01; 165(1):221-227.
-
Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism. Hypertension. 2018 09; 72(3):658-666.
-
Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism. JAMA Cardiol. 2018 08 01; 3(8):768-774.
-
Raber I, Isom RT, Louie JD, Vasanawala S, Bhalla V. A Novel High-Resolution Magnetic Resonance Imaging Protocol Detects Aldosterone-Producing Adenomas in Patients With Negative Computed Tomography. Am J Hypertens. 2018 07 16; 31(8):928-932.
-
Brown JM, Vaidya A. The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension. Ann Intern Med. 2018 05 15; 168(10):755-756.
-
Nanba K, Vaidya A, Rainey WE. Aging and Adrenal Aldosterone Production. Hypertension. 2018 02; 71(2):218-223.
-
Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018 01; 6(1):51-59.
-
Brown JM, Robinson-Cohen C, Luque-Fernandez MA, Allison MA, Baudrand R, Ix JH, Kestenbaum B, de Boer IH, Vaidya A. The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study. Ann Intern Med. 2017 Nov 07; 167(9):630-641.